Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Heart Diseases

• Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
• A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
• Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
• Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery
• Cardioprotective Effects of Cardiopeptides for Injection in Patients With Non-severe Cardiac Disease: a Single-center Randomized Controlled Trial
• A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)
• Therapy to Maintain Remission in Dilated Cardiomyopathy
• Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease
• Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
• A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) o
• A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease
• Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
• Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
• XTR003 PET Radiotracer for the Detection of Viable Myocardium
• Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions
• COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
• Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery
• Morphine IV vs Paracetamol IV in Neonates and Infants After Cardiac Surgery
• VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
• A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
• Tranexamic Acid Administration Strategies in Cardiovascular Surgery: Goal-directed vs. Empirical Tranexamic Acid Administration
• Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy
• A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
• Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness
• ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
• Effect of Anesthetics on Cardiac Biomarkers in Mitral and Aortic Valve Replacement/Plasty
• Theophylline Effects in the Fontan Circulation
• Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
• GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial
• Influence of Anesthetics on Clinical Outcome During Cardiac Surgery in Adults
• Rituximab in Patients With Acute Rheumatic Fever
• Dapagliflozin Effect on Rheumatic Mitral Stenosis
• Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
• A Preliminary Study for INFORMED
• " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
• The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy
• Ultrasound-Guided Serratus Anterior Plane Block Versus Erector Spinae Plane Block in Pediatric Cardiac Surgery
• Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
• HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation
• Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
• EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
• Effectiveness of CRD-740 in Heart Failure
• Effect of Perioperative Short-term Iron Treatment on Allogenic Blood Transfusion
• Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
• Therapeutic Study Evaluating the Efficacy of Noradrenaline in the Prevention of Hypotension Related to Intubation for Cardiac or Thoracic Surgery
• Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Resolute Stents Implantation; C-MODE Trial
• The Role of Dexmedetomidine As Myocardial Protection In Pediatric Cyanotic Congenital Heart Disease Undergoing Open Cardiac Surgery Using Cardiopulmonary Bypass Machine: A Preliminary Study
• Sugammadex Titration in Cardiac Surgery Patients
• Evaluation of CCR2 in Patients Post Myocardial Infarction
• High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease
• Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass
• Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery
• the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
• FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients
• Pilot Deprescribing Trials for Beta-blockers in Cardiac Amyloidosis
• Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
• Additive Anti-inflammatory Action for Critically Ill Patients With Cardiovascular Surgery (Xuebijing) IV
• Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
• Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Reduced Ejection Fraction (Syndrome of Qi Deficiency and Blood Stasis) Due to Coronary Heart Disease
• Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction
• Effect of MUSK Pill on the Patients With Chest Pain Due to Non Obstructive Coronary Artery Disease
• Telemonitoring to Treat Group 2 Pulmonary Hypertension
• Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
• Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
• Impact of Beta-blockers on Physical Function in HFpEF
• Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
• Role of Alprazolam in the Management of Acute Coronary Syndrome
• Serratus Anterior Plane Block Versus Standard of Care After Totally Endoscopic Aortic Valve Replacement
• Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
• Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
• Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
• Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment
• A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes
• Dopamine Versus Norepinephrine Under General Anesthesia
• The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression
• Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
• A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.
• The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia
• Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:
• Dexmedetomidine Neuroprotection in Pediatric Cardiac Surgery
• Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
• Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
• Thiamine Influenced on Substrate Energy Effectiveness in Indonesian Children Undergoing Cardiopulmonary Bypass
• ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery
• Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD
• Growth Hormone in Ischemic Heart Failure
• Heparin vs Placebo for Cardiac Catheterization
• Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease
• A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
• Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
• Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris
• Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury
• Different Modalities of Analgesia in Open Heart Surgeries in Mansoura University
• Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)
• Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
• NO During CPB in Neonates to Reduce Risk of AKI
• A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography
• Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
• Milrinone on Left Ventricular Diastolic Performance During Off-pump Coronary Artery Bypass Surgery
• Anticoagulation on Demand in Paroxysmal Atrial Fibrillation After Percutaneous Coronary Intervention
• One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
• Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease
• Fastigial Nucleus Stimulation for Coronary Heart Disease
• Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery
• Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)
• Effect of Empagliflozin on Ventricular Repolarization.
• Use of Oxandrolone to Promote Growth in Infants With HLHS
• Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
• Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow
• Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
• Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following Cardiac Surgery
• Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy
• Nitrite Effects on Cardiac Muscle in CABG
• Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease
• The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
• Effect of Thiamin Supplementation on Thiamin Status in Children With Heart Disease Receiving Diuretic Drugs
• Nitric Oxide During CPB to Reduce AKI in Neonates
• RIvoraxaban in Mitral Stenosis
• Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
• Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy
• A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)
• A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)
• The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)
• An Ascending Dose Comparison of MVT-100 to Definity in Healthy Volunteers
• The Cardioprotective Effects of Adding Ozone To Cardioplegic Solution in Adult Cardiac Surgery
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
• Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)
• Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
• Benign Prostatic Hyperplasia and Ischemic Heart DIsease
• Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertension
• An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
• The Randomized OPTIMAL-ACT Trial
• The Effect of Simvastatin Combined With Ezetimibe in Patients With Stable Angina and Diabetes
• DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
• IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).
• Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
• Pharmacokinetic Study of Dexmedetomidine After Intra-Nasal and Buccal Dosing in Children
• Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
• Ozone Therapy in Refractory Ischemic Heart Disease.
• Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
• Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
• Colchicine in Postoperative Fontan Patients
• DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
• Inhaled Anesthetics and Myocardial Strain
• Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)
• Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis
• Role of ARNi in Ventricular Remodeling in Hypertensive LVH
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
• 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease
• Comparing Ginkgo Biloba Pills and Placebo in the Treatment of Coronary Heart Disease With Impaired Glucose Regulation
• Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease
• Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
• The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients
• Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease
• Effect of Intranasal Insulin on POCD and POD
• Paravertebral Nerve Blocks in Neonates
• Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
• Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
• Determining the Impact of Penicillin in Latent RHD: The GOAL Trial
• Lidocaine as an Endotracheal Tube (ETT) Cuff Media
• Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation
• The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.
• Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
• STeroids to REduce Systemic Inflammation After Infant Heart Surgery
• DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant
• Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children
• Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation
• Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
• CES1 Carriers in the PAPI Study
• Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor
• Dexmedetomidine and the Inflammatory Response in Pediatric Cardiac Surgery
• PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes
• Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study
• Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects
• Metoprolol to Reduce Perioperative Myocardial Injury
• Maternal Hyperoxygenation in Congenital Heart Disease
• Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes
• Efficacy of Enhanced External Counterpulsation on Ventricular Function
• IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease
• Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status
• The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
• Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention
• Early Use of Vasopressin in Post-Fontan Management
• Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery
• Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study
• Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease
• Alirocumab and Reverse Cholesterol Transport
• A Extension Study of Udenafil in Adolescents
• Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
• Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease
• The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
• A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
• Efficacy and Safety of Aspirin Therapy With CABG
• Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease
• Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
• Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
• Remote Preconditioning and Myocardial Protection
• The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
• High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
• Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children
• INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
• INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority
• NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
• Randomized Anticoagulation Trial in Opcab (RATIO)
• Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
• Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
• Acute Effects of Inhaled Treprostinil in Fontan Patients
• Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease
• Fontan Udenafil Exercise Longitudinal Assessment Trial
• Multimodal Analgesia in Cardiac Surgery (Pilot Study)
• Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
• Studies of Application of Combined General Anesthesia and Bilateral TPVB in OPCABG
• Recovery Profiles of Remifentanil-based Regimen for Cardiac Surgery
• Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery
• Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
• STOP Heart Disease in Breast Cancer Survivors Trial
• Anesthetic Techniques in EP Patients
• Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
• Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease
• Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery
• Effect of Rosuvastatin Therapy on HDL2 Level
• Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
• Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
• Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
• Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI
• Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
• Clinical Study On The Relation Among Prescription, Syndrome and Disease of Turbid Phlegm and Blood Stasis for Coronary Heart Disease
• Dexmedetomidine in Children Having Transthoracic Echocardiography
• Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
• Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery
• Stress Response and Neurodevelopmental Outcome After Cardiac Surgery Utilizing CPB in Children: A Prospective, Double Blinded and Randomized Study
• Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
• Verapamil vs Heparin in Transradial Procedures
• Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
• GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
• Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
• Remifentanil and Glycemic Response in Cardiac Surgery
• Liraglutide to Improve corONary Haemodynamics During Exercise streSS
• RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial
• Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
• A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)
• Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy
• Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs
• Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents
• Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes
• Effect of Anesthetics on CD39 and CD73 After Open-heart Surgery
• Randomized Trial of Maternal Progesterone Therapy
• GLP-1 Loading During Elective Percutaneous Coronary Intervention
• Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
• Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
• A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007)
• Ticagrelor China Pharmacokinetic/Pharmacodynamic Study
• Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.
• Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
• Post-bypass Prophylactic IVIG in Infants and Neonates
• Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.
• Exparel in Minimally Invasive Cardiac Surgery
• Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
• Effect of Desflurane on Cardiac Function During Cardiac Surgery: Tissue Doppler Imaging of Mitral Valve Annular Velocity
• SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
• Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study
• ISCHEMIA-Chronic Kidney Disease Trial
• Comparison of Vascular Access for Radial and Femoral Completion of Diagnostic Cardiac Catheterization
• Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
• The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
• Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
• Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
• Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
• The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease
• The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
• The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates
• Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
• A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects
• Evaluating Precision of Therapy - Milrinone
• Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
• Propofol Effects on Mitral Valve Annular Velocity
• Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
• Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery
• Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery
• Study of Effects of Sildenafil on Patients With Fontan Heart Circulation
• Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
• Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
• Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery
• Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
• Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
• Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease
• Effect of GLP-1 on Postprandial Lipid Metabolism
• A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient
• DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)
• Lipid Biomarkers for Diabetic Heart Disease
• CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle
• Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
• N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement
• Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
• Fluvastatin AmelIorates aTHerosclerosis Study
• Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
• Elective Induction vs Spontaneous Labour in Patients With Heart Disease
• Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients
• Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery
• SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)
• Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
• Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
• Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft
• Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients
• The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
• A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
• Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
• Physiological Study of Human Cholesterol Metabolism and Excretion
• Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)
• Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
• ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
• Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)
• Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
• Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
• A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease
• Fontan Patients: Comprehensive Evaluation of Pulmonary Circulation and Ventricular Function
• Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery
• Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study
• Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease
• Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
• Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
• Relationship Between the Menstrual Cycle and Heart Disease in Women
• A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
• A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis
• Sevoflurane's Effect on Mitral Valve Annular Velocity in Cardiac Surgery
• The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols
• Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index
• Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions
• Effects of N-acetylcysteine on Low T3 Syndrome
• Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
• The Cortisol Levels During Cardiac Surgery. The Comparison Between Etomidate and Thiopentone
• Ranolazine for Improving Symptoms of Palpitations
• The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery
• Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery
• The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
• Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
• Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
• The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery
• The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial
• Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers
• A Prospective Study to Evaluate the Effect of Chronic Nitrate Therapy on Vasodilation Function in Coronary Heart Disease
• Preventing Brain Injury in Infants With Congenital Heart Disease
• Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
• Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
• Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
• Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
• Reducing Delirium After Cardiac Surgery: A Multifaceted Approach Of Perioperative Care
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• Pilot Study of Using Copeptin to Predict Response to Tolvaptan
• A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
• Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease
• Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
• A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)
• Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
• Real-time MRI Right Heart Catheterization Using Passive Catheters
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
• A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
• Comprehensive Evaluation of Ischemic Heart Disease Using MRI
• Treatment of Coronary Heart Disease With Amiloride
• Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
• Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks
• Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease
• Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)
• Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease
• Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
• Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery
• Effect of Simvastatin on Cardiac Function
• Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting
• Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery
• Sildenafil in Single Ventricle Patients
• Comparison of Generic and Original Formulation of Clopidogrel
• Niacin/Laropiprant and Endothelial Function
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3)
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)
• Spironolactone in Adult Congenital Heart Disease
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers
• Aspirin in Reducing Events in the Elderly
• Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
• Tranexamic Acid in Pediatric Cardiac Surgery
• Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
• Endothelin Blockade in Patients With Single Ventricle Physiology
• Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass
• Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
• Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
• The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man - A Bradykinin Dependent Pathway
• The Effect of Ischaemic-Reperfusion in Man - A Bradykinin Dependent Pathway
• Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
• Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine
• Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
• Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease
• Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
• Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
• A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
• Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease
• Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180
• Stress Echocardiography Study With Regadenoson
• Interaction of Apelin and Angiotensin in the Human Forearm Circulation
• Interaction of Apelin and Angiotensin in the Human Forearm Circulation
• Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation
• Gap Junction Potentiation of Endothelial Function With Rotigaptide
• Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
• Selenium Treatment and Chagasic Cardiopathy (STCC)
• Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
• Phytosterols, Ezetimibe, and Cholesterol Metabolism
• Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease
• Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children
• Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease
• Acarbose Cardiovascular Evaluation Trial
• Aspirin Responsiveness in Women at Risk for Cardiac Events
• Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)
• Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery
• Evaluating the Effects of Folic Acid Supplementation in Older Adults: The Folic Acid Supplementation Trial (The FAST Study)
• Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
• Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
• Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis
• The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery
• Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients
• Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery
• Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients
• Persantin Preceding Elective PCI
• Proteolytic Enzyme Induction Within the Human Myocardial Interstitium
• Rapid Versus Prolonged Inpatient Up-Titration of Captopril
• Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <> (Study P05464)
• Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.
• Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
• Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
• Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
• Using Beta Blockers to Treat Mitral Regurgitation
• Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
• Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
• Intravenous Versus Intracoronary Use of Abciximab
• Risk Reduction in Coronary Heart Disease
• Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist
• Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
• Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
• A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
• A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
• A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease
• Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks
• Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
• Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA
• Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)
• Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
• Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
• Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
• Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
• Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
• Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
• Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
• Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass
• Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
• Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin
• The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease
• Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years
• Pharmacokinetics of Ketamine in Infants and Children
• Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease
• Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
• A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)
• Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease
• A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-1
• An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)
• 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
• Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death
• Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
• Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
• Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
• A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP
• Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons
• The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
• Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
• Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
• Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease
• Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
• Cholesterol and Pharmacogenetic Study
• A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis
• Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?
• Endothelin-Receptor Blockade in Coronary Heart Disease
• The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
• Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
• Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
• Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
• A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
• Improving Metabolism With HDL Cholesterol
• Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
• N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)
• Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
• A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
• Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
• EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine)
• Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
• A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
• Heart and Estrogen-Progestin Replacement Study (HERS)
• Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
• Exercise to Treat Depression in Individuals With Coronary Heart Disease
• Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
• Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
• Dexamethasone for Cardiac Surgery Trial
• Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
• A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention
• Cell Therapy for Coronary Heart Disease
• The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol
• Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease
• Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
• A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass
• Conditioned Placebo Effects and Treatment of Hypertension
• SB-480848 In Subjects With Coronary Heart Disease
• Optimum Platelet Inhibition After Coronary Bypass Surgery
• Metabolic Analysis in Human Sulfur Amino Acid Deficiency
• MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
• Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
• Moxonidine in Patients Undergoing Vascular Surgery
• Reducing Total Cardiovascular Risk in an Urban Community
• Uric Acid and Hypertension in African Americans
• Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)
• Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
• Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
• Effects of Citalopram on Hostility and CHD Risk
• A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
• Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
• Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
• N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery
• EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
• A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass
• Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy
• Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
• Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
• The Use of HEMOBAG to Salvage Blood After Cardiac Surgery
• A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade
• A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators
• A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography
• A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
• Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
• Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
• The Effect of Xenical on Weight and Risk Factors
• QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia
• Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
• Chinese Community Smoking Cessation Project
• A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
• A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
• A Morbidity-Mortality and Remodeling Study With Valsartan
• Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
• Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass
• Peroral Levosimendan in Chronic Heart Failure
• Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass
• Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure
• Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
• BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease
• Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
• The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease
• Niacin Plus Statin to Prevent Vascular Events
• Electrophysiological Effects of Late PCI After MI
• Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
• Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
• NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
• Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
• Fluoxetine as a Quit Smoking AID for Depression Prone
• Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers
• Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
• Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia
• Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
• An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)
• Sitosterolemia Extension Study (0653-004)(COMPLETED)
• Sitosterolemia Extension Study (0653-003)(COMPLETED)
• An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
• Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)
• Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)
• Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
• Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
• IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
• Estrogen, HDL, and Coronary Heart Disease in Women
• Use of Nesiritide in the Management of Acute Diastolic Heart Failure
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
• Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
• Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
• A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
• ACE Inhibition and Novel Cardiovascular Risk Factors
• Stop Atherosclerosis in Native Diabetics Study
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
• Estrogen, Cytokines and Heart Failure in Women
• Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
• Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
• Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
• Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
• Genetic Epidemiology of Responses to Antihypertensives
• Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal
• The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
• Occluded Artery Trial (OAT)
• Azithromycin and Coronary Events Study (ACES)
• Prevention of Recurrent Venous Thromboembolism (PREVENT)
• CVD Risk and Health in Postmenopausal Phytoestrogen Users
• Soy Estrogen Alternative Study (SEA)
• Women's Health Initiative (WHI)
• Magnesium in Coronaries (MAGIC)
• Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
• Estrogen and Graft Atherosclerosis Research Trial (EAGER)
• Postmenopausal Hormone Therapy in Unstable Angina
• Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
• NHLBI Type II Coronary Intervention Study
• Beta-Blocker Evaluation in Survival Trial (BEST)
• Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
• Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
• Women's Angiographic Vitamin and Estrogen Trial (WAVE)
• HDL-Atherosclerosis Treatment Study (HATS)
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
• Estrogen Replacement and Atherosclerosis (ERA) in Older Women
• Enalapril After Anthracycline Cardiotoxicity
• Oral Calcium in Pregnant Women With Hypertension
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
• Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
• Arterial Disease Multifactorial Intervention Trial (ADMIT)
• Calcium for Pre-Eclampsia Prevention (CPEP)
• Antiarrhythmics Versus Implantable Defibrillators (AVID)
• Raynaud's Treatment Study (RTS)
• Tamoxifen Study
• Recurrent Carotid Stenosis
• Cardiac Arrhythmia Suppression Trial (CAST)
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
• Myocarditis Treatment Trial
• Treatment of Mild Hypertension Study (TOMHS)
• Prevention of Coronary Aneurysms in Kawasaki Syndrome
• Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
• Studies of Left Ventricular Dysfunction (SOLVD)
• Systolic Hypertension in the Elderly Program (SHEP)
• Trial of Antihypertensive Intervention Management
• Familial Atherosclerosis Treatment Study
• Platelet-Inhibitor Drug Trial in Coronary Angioplasty
• Intravenous Streptokinase in Acute Myocardial Infarction
• Cardiovascular System in Obesity: Effect of Treatment
• Thrombolysis in Myocardial Infarction (TIMI)
• Cardiac Arrhythmia Pilot Study (CAPS)
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
• Hypertension Prevention Trial (HPT) Feasibility Study
• Physicians' Health Study
• Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
• Control of Hypertension by Non-Pharmacologic Means
• Platelet Drug Trial in Coronary Disease Progression
• Management of Patent Ductus in Premature Infants
• Multicenter Investigation of Limitation of Infarct Size (MILIS)
• Beta-Blocker Heart Attack Trial (BHAT)
• Aspirin-Myocardial Infarction Study (AMIS)
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
• Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
• Hypertension Detection and Follow-up Program (HDFP)
• Treatment of Hypertension
• Coronary Drug Project Mortality Surveillance
• Coronary Drug Project
• Multicenter Unsustained Tachycardia Trial (MUSTT)
• Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
• Cholesterol Reduction in Seniors Program (CRISP)
• Digitalis Investigation Group (DIG)
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)
• Asymptomatic Carotid Artery Plaque Study (ACAPS)
• Myocardial Infarction Triage and Intervention Project (MITI)
• Postmenopausal Estrogen/Progestin Interventions (PEPI)
• Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
• Post Coronary Artery Bypass Graft (CABG) Study
• Harvard Atherosclerosis Reversibility Project (HARP)